Modification of epinephrine-induced arrhythmias by N-Acetyl-L-Cysteine and vitamin e

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 14, Issue 2, 2009, Pages 134-142

  Sethi, Rajat ^a   Adameova, Adriana ^b   Dhalla, Ken S ^b   Khan, Mohsin ^b   Elimban, Vijayan ^b   Dhalla, Naranjan S ^b,c  

^a TEXAS A AND M UNIVERSITY KINGSVILLE   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

^c ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

Aminochromes; Catecholamine induced arrhythmias; Nacetyl L cysteine; Oxidation products of catecholamines; Vitamin E

Indexed keywords

ACETYLCYSTEINE; ADRENALIN; ALPHA TOCOPHEROL; AMINE; AMINOCHROME; MALONALDEHYDE; NORADRENALIN; UNCLASSIFIED DRUG;

ADRENALIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; ELECTROCARDIOGRAM; HEART SINOATRIAL BLOCK; HEART VENTRICLE ARRHYTHMIA; LIPID PEROXIDATION; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PREMEDICATION; PRIORITY JOURNAL; RAT;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; ARRHYTHMIAS, CARDIAC; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; EPINEPHRINE; FREE RADICAL SCAVENGERS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN E;

EID: 65949112035     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/1074248409333855     Document Type: Article

References (42)

1. Bhagat BD, Rao PS, Dhalla NS Role of catecholamines in the genesis of arrhythmias. Adv Myocardiol. 1980 ; 2: 117-132.
2. Podzuweit T. Catecholamine-cyclic-AMP-Ca2+-induced ventricular tachycardia in the intact pig heart. Basic Res Cardiol. 1980 ; 75 (6). 772-779. (Pubitemid 11183578)
3. Podzuweit T., Els DJ, McCarthy J. Cyclic AMP mediated arrhythmias induced in the ischaemic pig heart. Basic Res Cardiol. 1981 ; 76 (4). 443-448. (Pubitemid 11042625)
4. Opie L. Receptors and signal transduction. In The Heart: Physiology, From Cell to Circulation. Philadelphia, PA: Lippincott, Williams and Wilkins ; 1998: 173-207.
5. Karmazyn M., Beamish RE, Fliegel L., Dhalla NS Adrenochrome-induced coronary artery constriction in the rat heart. J Pharmacol Exp Ther. 1981 ; 219 (1). 225-230. (Pubitemid 11018655)
6. Beamish RE, Dhillon KS, Singal PK, Dhalla NS Protective effect of sulfinpyrazone against catecholamine metabolite adrenochrome-induced arrhythmias. Am Heart J. 1981 ; 102 (2). 149-152. (Pubitemid 11053140)
7. Singal PK, Dhillon KS, Beamish RE, Kapur N., Dhalla NS Myocardial cell damage and cardiovascular changes due to i.v. infusion of adrenochrome in rats. Br J Exp Pathol. 1982 ; 63 (2). 167-176.
8. Takeo S., Taam GM, Beamish RE, Dhalla NS Effect of adrenochrome on calcium accumulation by heart mitochondria. Biochem Pharmacol. 1981 ; 30 (2). 157-163. (Pubitemid 11210844)
9. Doppalapudi H., Jin Q., Dosdall DJ, et al. Intracoronary infusion of catecholamines causes focal arrhythmias in pigs. J Cardiovasc Electrophysiol. 2008 ; 19 (9). 963-970.
10. Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol. 1985 ; 17 (4). 291-306. (Pubitemid 15030720)
11. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens. 2000 ; 18 (6). 655-673. (Pubitemid 30406736)
12. Dhalla NS, Elmoselhi AB, Hata T., Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res. 2000 ; 47 (3). 446-456. (Pubitemid 30646067)
13. Dhalla NS, Sasaki H., Mochizuki S., Dhalla KS, Liu X., Elimban V. Pathogenesis of catecholamine-induced cardiomyopathy. In Acosta D Jr, ed. Cardiovascular Toxicology. 4 th ed. New York: Informa Healthcare ; 2008: 207-262.
14. Diaz MN, Frei B, Vita JA, Keaney JF Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med. 1997 ; 337 (6). 408-416. (Pubitemid 27328371)
15. Honarbakhsh S., Schachter M. Vitamins and cardiovascular disease. Br J Nutr. 2008 ; 1-19 [Epub ahead of print].
16. Zingg JM, Azzi A. Non-antioxidant activities of vitamin E. Curr Med Chem. 2004 ; 11 (9). 1113-1133. (Pubitemid 38585057)
17. Mosnier LO, Griffin JH Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activities. Front Biosci. 2006 ; 11: 2381-2399. (Pubitemid 43806554)
18. Fedelesova M., Sulakhe PV, Yates JC, Dhalla NS Biochemical basis of heart function. IV. Energy metabolism and calcium transport in hearts of vitamin E deficient rats. Can J Physiol Pharmacol. 1971 ; 49 (10). 909-918.
19. Dhalla KS, Rupp H., Beamish RE, Dhalla NS Mechanisms of alterations in cardiac membrane Ca2+ transport due to excess catecholamines. Cardiovasc Drugs Ther. 1996 ; 10 (suppl 1). 231-238. (Pubitemid 126426087)
20. Tappia PS, Hata T., Hozaima L., Sandhu MS, Panagia V., Dhalla NS Role of oxidative stress in catecholamine-induced changes in cardiac sarcolemmal Ca2+ transport. Arch Biochem Biophys. 2001 ; 387 (1). 85-92. (Pubitemid 32989028)
21. Sethi R., Takeda N., Nagano M., Dhalla NS Beneficial effects of vitamin E treatment in acute myocardial infarction. J Cardiovasc Pharmacol Ther. 2000 ; 5 (1). 51-58. (Pubitemid 30082873)
22. Tang LD, Sun JZ, Wu K., Sun CP, Tang ZM Beneficial effects of N-acetylcysteine and cysteine in stunned myocardium in perfused rat heart. Br J Pharmacol. 1991 ; 102 (3). 601-606.
23. Forman MB, Puett DW, Cates CU, et al. Glutathione redox pathway and reperfusion injury. Effect of N-acetylcysteine on infarct size and ventricular function. Circulation. 1988 ; 78 (1). 202-213. (Pubitemid 18180461)
24. Matejikova J., Kucharska J., Pinterova M., Pancza D., Ravingerova T. Protection against ischaemia-induced ventricular arrhythmias and myocardial dysfunction conferred by preconditioning in the rat heart: involvement of mitochondrial K(ATP) channels and reactive oxygen species. Physiol Res. 2008 ; [Epub ahead of print].
25. Ozaydin M., Peker O., Erdogan D., et al. N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. Eur Heart J. 2008 ; 29 (5). 625-631.
26. Vento AE, Nemlander A., Aittom?Currency signki J., Salo J., Karhunen J., R?Currency signm?¶ OJ N-acetylcysteine as an additive to crystalloid cardioplegia increased oxidative stress capacity in CABG patients. Scand Cardiovasc J. 2003 ; 37 (6). 349-355. (Pubitemid 38159352)
27. El-Hamamsy I., Stevens LM, Carrier M., et al. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg. 2007 ; 133 (1). 7-12. (Pubitemid 46014198)
28. Barta J., Sanganalmath SK, Kumamoto H., Takeda N., Edes I., Dhalla NS Antiplatelet agents sarpogrelate and cilostazol affect experimentally-induced ventricular arrhythmias and mortality. Cardiovasc Toxicol. 2008 ; 8 (3). 127-135.
29. Walker MJ, Curtis MJ, Hearse DJ, et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res. 1988 ; 22 (7). 447-455. (Pubitemid 18173716)
30. Dhalla KS, Ganguly PK, Rupp H., Beamish RE, Dhalla NS Measurement of adrenolutin as an oxidation product of catecholamines in plasma. Mol Cell Biochem. 1989 ; 87 (1). 85-92. (Pubitemid 19146282)
31. Buege JA, Aust SD Microsomal lipid peroxidation. Methods Enzymol. 1978 ; 52: 302-310.
32. Selye H. The Pluricausal Cardiopathies. Springfield, IL: Charles C Thomas ; 1961.
33. Wortsman J. Role of epinephrine in acute stress. Endocrinol Metab Clin North Am. 2002 ; 31 (1). 79-106. (Pubitemid 34578615)
34. Wortsman J., Frank S., Cryer PE Adrenomedullary response to maximal stress in humans. Am J Med. 1984 ; 77 (5). 779-784. (Pubitemid 15204853)
35. Singal PK, Beamish RE, Dhalla NS Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol. 1983 ; 161: 391-401.
36. Linseisen J., Hoffmann J., Riedl J., Wolfram G. Effect of a single oral dose of antioxidant mixture (vitamin E, carotenoids) on the formation of cholesterol oxidation products after ex vivo LDL oxidation in humans. Eur J Med Res. 1998 ; 3 (1-2). 5-12.
37. Ithayarasi AP, Padmavathy VN, Shyamala Devi C. Effect of alpha-tocopherol on isoproterenol induced myocardial infarction in rats-electrocardiographic biochemical and histological evidences. Indian J Physiol Pharmacol. 1996 ; 40 (4). 297-302. (Pubitemid 26420809)
38. Tejero-Taldo MI, Caffrey JL, Sun J., Mallet RT Antioxidant properties of pyruvate mediate its potentiation of beta-adrenergic inotropism in stunned myocardium. J Mol Cell Cardiol. 1999 ; 31 (10). 1863-1872. (Pubitemid 29458704)
39. Shite J., Qin F., Mao W., Kawai H., Stevens SY, Liang C. Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy. J Am Coll Cardiol. 2001 ; 38 (6). 1734-1740. (Pubitemid 33065463)
40. Liang C., Rounds NK, Dong E., Stevens SY, Shite J., Qin F. Alterations by norepinephrine of cardiac sympathetic nerve terminal function and myocardial beta-adrenergic receptor sensitivity in the ferret: normalization by antioxidant vitamins. Circulation. 2000 ; 102 (1). 96-103. (Pubitemid 30430559)
41. Trankmann P., Thiele R., Winnefeld K., Seliger K. Effect of administration of selenium and vitamin E on heart failure and ventricular arrhythmias in patients with acute myocardial infarct. Med Klin (Munich). 1999 ; 94 (suppl 3). 78-80. (Pubitemid 29528800)
42. Marchetti G., Lodola E., Licciardello L., Colombo A. Use of N-acetylcysteine in the management of coronary artery disease. Cardiologia. 1999 ; 44 (7). 633-637.